author-photo

Marie Claire Roderick

National Institutes of Health

12

Papers

234

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Impact of MEK inhibitor therapy on neurocognition in neurofibromatosis type 1

2020 medRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Selumetinib in Children with Inoperable Plexiform Neurofibromas.

2020 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (133)
Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings

2019 Neuropsychological Rehabilitation
Show All
- Source
- Cite
- Save
Citations (5)
QOL-55. HOME PHYSICAL ACTIVITY INTERVENTION TO IMPROVE COGNITIVE LATE EFFECTS IN CHILDREN TREATED WITH RADIATION FOR BRAIN TUMORS: DESCRIPTIVE FEASIBILITY DATA FROM A PILOT RANDOMIZED CONTROLLED TRIAL (RCT)

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy

2018 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (33)
NFM-07. SPRINT: PHASE II STUDY OF THE MEK 1/2 INHIBITOR SELUMETINIB (AZD6244, ARRY-142886) IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1) AND INOPERABLE PLEXIFORM NEUROFIBROMAS (PN)

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (7)
Feasibility and Preliminary Efficacy of an Internet Support Group for Parents of a Child with Neurofibromatosis Type 1: a Pilot Study

2017 Journal of Genetic Counseling
Show All
- Source
- Cite
- Save
Citations (4)
SPRINT: Phase II study of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886) in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (20)